1. Home
  2. SURG vs COEP Comparison

SURG vs COEP Comparison

Compare SURG & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$0.84

Market Cap

18.3M

ML Signal

HOLD

Logo Coeptis Therapeutics Holdings Inc.

COEP

Coeptis Therapeutics Holdings Inc.

HOLD

Current Price

$11.70

Market Cap

100.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
COEP
Founded
2006
2017
Country
United States
United States
Employees
20
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
100.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SURG
COEP
Price
$0.84
$11.70
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.75
N/A
AVG Volume (30 Days)
224.8K
42.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.78
N/A
Revenue Next Year
$113.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$6.32
52 Week High
$3.47
$21.41

Technical Indicators

Market Signals
Indicator
SURG
COEP
Relative Strength Index (RSI) 36.13 41.86
Support Level $0.75 $10.74
Resistance Level $3.12 $12.71
Average True Range (ATR) 0.06 0.74
MACD 0.03 0.09
Stochastic Oscillator 33.94 35.87

Price Performance

Historical Comparison
SURG
COEP

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: